Stem Cell Therapy For Acute Ischemic Stroke Patients (InVeST)
Intravenous Autologous Bone Marrow-derived Stem Cells Therapy for Patients With Acute Ischemic Stroke: A Multi-Institutional Project
Sponsor: All India Institute of Medical Sciences
Listed as NCT02425670, this PHASE2 trial focuses on Anterior Cerebral Artery Infarction and Middle Cerebral Artery Infarction and remains completed. Sponsored by All India Institute of Medical Sciences, it has been updated 8 times since 2009, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Jul 2025 — Present [monthly]
Completed PHASE2
-
May 2025 — Jul 2025 [monthly]
Completed PHASE2
-
Sep 2024 — May 2025 [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Apr 2024 — Jul 2024 [monthly]
Completed PHASE2
▶ Show 3 earlier versions
-
Jan 2021 — Apr 2024 [monthly]
Completed PHASE2
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE2
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE2
First recorded
Jan 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- All India Institute of Medical Sciences
- Armed Forces Medical College, Pune
- Army Hospital Research And Referral, India
- Ministry of Science and Technology, India
- Post Graduate Institute of Medical Education and Research, Chandigarh
- Sanjay Gandhi Postgraduate Institute of Medical Sciences
For direct contact, visit the study record on ClinicalTrials.gov .